Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This move positioned Roche to compete in the metabolic disease arena, leveraging Carmots small molecule platforms to diversify beyond oncology.[3] (2023): AstraZenecas Acquisition of CinCor Pharma Though primarily targeting hypertension, AstraZenecas US$1.8 billion buyout of CinCor included a nod toward combinational potential with metabolic therapies, signaling broader interest in cardiometabolic synergies.[4] (2024, 2025): Pfizers Strategic Reassessment and Potential for Acquisitions After halting internal development of its oral GLP-1 candidate due to tolerability concerns, Pfizer has publicly stated its interest in acquiring external GLP-1 assets
Doctors often prescribe tamoxifen after chemotherapy or radiation to lower the chances of breast cancer returning (recurrence)
Attention-deficit hyperactivity disorder (ADHD) is characterized by difficulties in attention and motor control, often accompanied by impulsive behavior
Additional studies are needed to clarify the mechanisms involved and to improve LipRSV treatment approaches
US$ 24.83
US$ 25.48
US$ 25.07
US$ 21.38
US$ 25.32
US$ 28.55
